Founded in 1886 with the initial idea that wounds should be treated and dressed using sterile equipment, Johnson & Johnson has become not only one of the largest healthcare companies in the world today but also one of the most profitable. The company specializes in areas of orthopedic, cardiovascular, diabetes, vision care, and surgery. In March 2020, Johnson and Johnson launched a partnership with the US Department of Health and Human Services with an aim to roll out vaccines in January 2021. Johnson and Johnson are in phase 3 of their COVID-19 vaccine candidate, which will assess the safety and efficacy of up to 60,000 participants, including diverse individuals disproportionately affected by COVID-19.